A carregar...

Considerations for a Pediatric Biopharmaceutics Classification System (BCS): Application to Five Drugs

It has been advocated that biopharmaceutic risk assessment should be conducted early in pediatric product development and synchronized with the adult product development program. However, we are unaware of efforts to classify drugs into a Biopharmaceutics Classification System (BCS) framework for pe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gandhi, Shivani V., Rodriguez, William, Khan, Mansoor, Polli, James E.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4037489/
https://ncbi.nlm.nih.gov/pubmed/24557773
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12249-014-0084-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!